The report on global insulin pumps market has been classified on the basis of three categories product type, distribution channels, and geography (regions & countries). Major product segment included insulin pumps and insulin pump supplies & accessories. The report offers a detailed description behind the steady growth rate of the market and a possible growth trajectory at the global as well as regional level in terms of value and the market share for each insulin pumps segment. The report is thus, compiled with the prime intent of updating the stakeholders with the incumbent market dynamics through a graphical illustration and in-depth analysis of each segment considered within the study scope. The global Insulin Pumps Market was valued at US$ 4,180.4 Mn in 2016 and is expected to grow at a high CAGR of 9.8% from 2017 to 2025, to reach an estimated value of US$ US$ 9,550.7 Mn in 2025.
Based on product type of insulin pumps market, insulin pumps products remained the key contributor towards the global market, which accounted for approximately 70.1% of the global market in 2016. The global insulin pumps market is growing at a steady rate due to high awareness about tethered insulin pumps among type-1 diabetes patients, adoption of advanced technological products such as patch/disposable pumps, and increase in prevalence of diabetes among the elderly people. In addition, preference for insulin pumps over reusable insulin injection pens is increasing due to better efficiency in terms of dosage and user friendly advantages offered by insulin pump products. Insulin pump supplies & accessories is the second leading revenue generator product segment for the global insulin pumps market. Insulin pump supplies & accessories are low cost, but sold in higher volumes than insulin pumps. Insulin pump supplies include products such as insulin cartridges, tubing, and infusion sets. These products are initially provided as a part of insulin pump, but can be procured separately.
Based on distribution channels segment, hospital pharmacy held the largest share among the major distribution channels categories accounting for more than 38.1% share of global market in 2016. Hospitals have remained the most preferred choice and highly favorable distribution channels for insulin pumps. Prevalence of diabetes among hospitalized patients is the major factor that drives demand for insulin pumps at hospital pharmacies. Therefore, the segment is expected to witness strong growth during the forecast period. Hospital pharmacy are followed by retail pharmacy which accounted for around 22.9% share of global market in 2016. The segment is driven by increasing prevalence of diabetes, especially among the geriatric population. Online sales segment is expected to register rapid growth due to increasing popularity, and rising preference for online sales for healthcare products in most of the regions of the world is the key factor that boost the demand for insulin pumps, especially among developed countries such as the U.S., Germany and the U.K. Diabetes Clinics/Centers are accounted for around 18.1% share of global insulin pumps market in 2016.
The key players operating in the Insulin Pumps Market are Medtronic, Cellnovo Group SA, F. Hoffmann-La Roche Ltd., Animas Corporation (Johnson & Johnson), Valeritas, Inc., Tandem Diabetes Care, Inc., SOOIL Developments Co., Ltd, and Insulet Corporation, Ypsomed AG, Jiangsu Delfu Co., Ltd. The global Insulin Pumps Market is fragmented with presence of few large and small scale vendors that operates global market. However, the global market is dominated by three major players.
Download a PDF Brochure or TOC of the Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=29453